De-novo expression of CD44 and survival in gastric cancer
- 1 October 1993
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 342 (8878), 1019-1022
- https://doi.org/10.1016/0140-6736(93)92879-x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.The Journal of Experimental Medicine, 1993
- Expression of CD44R1 adhesion molecule in colon carcinomas and metastasesThe Lancet, 1993
- CD44 and cancerThe Lancet, 1993
- A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.The Journal of cell biology, 1993
- Participation in Normal Immune Responses of a Metastasis-Inducing Splice Variant of CD44Science, 1992
- Measurement of an adhesion molecule as an indicator of inflammatory disease activity: Up‐regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritisArthritis & Rheumatism, 1991
- Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons.The Journal of cell biology, 1991
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- High levels of CD44 expression distinguish virgin from antigen-primed B cells.The Journal of Experimental Medicine, 1991
- CD44 — A molecule involved in leukocyte adherence and T-cell activationImmunology Today, 1989